Patents by Inventor Heidi Jessup

Heidi Jessup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically Engineered Cells and Uses Thereof
    Publication number: 20220195396
    Abstract: Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 23, 2022
    Inventors: Michael Naso, Jill Carton, Mark Wallet, Barry Morse, Luis Borges, Buddha Gurung, Hillary Quinn, Liam Campion, Heidi Jessup, Kenneth Brasel, Lucas Thompson
  • Genetically Engineered Cells and Uses Thereof
    Publication number: 20220184123
    Abstract: Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing a chimeric antigen receptor (CAR) and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 16, 2022
    Inventors: Michael Naso, Jill Carton, Mark Wallet, Barry Morse, Luis Borges, Hillary Quinn, Liam Campion, Buddha Gurung, Heidi Jessup, Kenneth Brasel, Lucas Thompson
  • METHODS AND COMBINATIONS FOR TREATMENT AND T CELL MODULATION
    Publication number: 20220008477
    Abstract: The present disclosure relates in some aspects to methods, compositions and uses involving immunotherapies, such as adoptive cell therapy, e.g., T cell therapy, and an immunomodulatory compound, such as a structural or functional analog or derivative of thalidomide and/or an inhibitor of E3-ubiquitin ligase. The provided methods, compositions and uses include those for combination therapies involving the administration or use of one or more immunomodulatory compounds in conjunction with a T cell therapy, such as a genetically engineered T cell therapy involving cells engineered with a recombinant receptor, such as chimeric antigen receptor (CAR)-expressing T cells. Also provided are compositions, methods of administration to subjects, articles of manufacture and kits for use in the methods.
    Type: Application
    Filed: November 7, 2019
    Publication date: January 13, 2022
    Applicant: Juno Therapeutics, Inc.
    Inventors: Jens HASSKARL, Stanley R. FRANKEL, Michael PORTS, Michael POURDEHNAD, Heidi JESSUP, Yue JIANG, Jim Shi Xiang QIN, Neha SONI, Melissa WORKS
  • Ergonomic soft-feel mouse
    Publication number: 20020075236
    Abstract: A new ergonomic soft feel mouse is provided. The soft feel mouse includes a palm rest that is softer and squishier than palm rests of other mouses. The palm rest includes a gel layer that provides the soft and squishy feel. The gel layer can be formed using a liquid gel that is molded. The palm rest may also include a foam layer and/or a film layer.
    Type: Application
    Filed: January 24, 2002
    Publication date: June 20, 2002
    Applicant: FELLOWES MANUFACTURING COMPANY
    Inventors: Howard L. Danzyger, Heidi Jessup, Chris Jones
  • Ergonomic soft-feel mouse
    Patent number: 6390423
    Abstract: A new ergonomic soft feel mouse is provided. The soft feel mouse includes a palm rest that is softer and squishier than palm rests of other mouses. The palm rest includes a gel layer that provides the soft and squishy feel. The gel layer can be formed using a liquid gel that is molded. The palm rest may also include a foam layer and/or a film layer.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: May 21, 2002
    Assignee: Fellowes, Inc.
    Inventors: Howard L. Danzyger, Heidi Jessup, Chris Jones